Health Screening in Your 60s and Beyond: What Stays, What Stops

In your 60s and beyond, useful screening becomes more selective rather than more intensive: a handful of tests keep their value, several cancer programmes reach a recommended upper age, and a few new checks such as bone density begin. The instinct to test everything more often as the years add up is understandable, but the evidence points the other way. The right question is no longer “what else can we check?” but “which checks will still change anything for me?”

Why screening changes after 60

Screening after 60 is governed by a simple idea: a test only helps if you would live long enough to benefit from catching something early, and if you would act on what it finds. Many conditions take years to cause harm, so the benefit of finding them early arrives years later. That is why later-life screening leans on overall health and life expectancy, not birthday age alone. People are living longer, and a 65-year-old today often has decades ahead, but health varies enormously between individuals of the same age ¹.

This is also where the harms of testing carry more weight. The older the symptom-free population, the more false positives, incidental findings and overdiagnosis a wide net produces, each capable of triggering further scans, biopsies or procedures that carry their own risk. Doing fewer, better-chosen tests is not rationing; it is matching care to the person in front of you.

What stays: the checks that keep earning their place

Several screens stay firmly worthwhile because the conditions they catch remain common, silent and treatable in later life.

• Blood pressure: still the highest-value, lowest-effort check. High blood pressure usually has no symptoms and remains a leading modifiable cause of stroke and heart disease worldwide, with an estimated 1 in 3 adults aged 30 to 79 affected, many unaware ². A reading takes under a minute.
• Blood glucose: type 2 diabetes can be present for years without symptoms, so periodic checks remain sensible. Widely used thresholds are an HbA1c of 6.5% (48 mmol/mol) or a fasting glucose of 7.0 mmol/L (126 mg/dL) for diabetes.
• Cholesterol and lipids: cardiovascular risk stays relevant, though management in older adults is more individualised. Whether to start, continue or stop lipid treatment is a decision made with a clinician, not by a fixed cut-off.

National bodies that grade the evidence, such as the U.S. Preventive Services Task Force, publish age-specific guidance that clinicians use to decide what is genuinely worth testing at each stage of life ³. The pattern is consistent: keep the high-yield checks, drop the rest.

What stops: tests with an upper age limit

Most population cancer screening programmes have a recommended upper age, because the balance of benefit to harm shifts as competing health risks rise.

• Colorectal (bowel) screening: stool tests (FIT) or colonoscopy typically run to about age 74, with stool testing usually annual or biennial and colonoscopy roughly every 10 years. Exact ages vary by country.
• Breast screening: mammography programmes commonly invite women to around 74, at 1 to 3 year intervals, weighing earlier detection against false positives and overdiagnosis.
• Cervical screening: HPV-based screening commonly runs to around 65, and screening can often stop after an adequate history of normal results.

Reaching a programme’s upper age does not mean a hard wall. It means routine invitations stop and any further screening becomes an individual conversation about your health and likely benefit, rather than an automatic call. For an overview of how each cancer screen works and who it is for, see our cancer screening overview at /guides/cancer-screening-overview.

What begins: new checks for this decade

Some screening starts rather than ends in your 60s. Bone density is the clearest example. Osteoporosis is screened with a DXA scan, reported as a T-score: −1.0 and above is normal, −1.0 to −2.5 is low bone mass, and −2.5 or below is osteoporosis ⁴. DXA screening commonly begins for women around age 65, and earlier for anyone with risk factors such as a previous fragility fracture, low body weight or long-term steroid use. The scan is quick and uses very little radiation. You can read more about what the result means in our guide at /guides/bone-density-screening.

Beyond bone health, later life is when reviews of vision, hearing, mood, falls risk and medication lists become part of a good checkup, even though these are assessments rather than classic screening tests. They tend to surface problems that quietly erode independence.

Building a later-life plan that fits you

A sensible plan after 60 is risk-based, not maximal. It weighs your age, sex, family history and personal risk against the benefits and harms of each test, follows recommended intervals rather than testing constantly, and is decided with a clinician who knows your history. This matters more with each decade, because guideline bodies often disagree at the edges and because individual health diverges so widely.

It is worth being wary of one tempting shortcut. Broad whole-body or “executive” screening packages marketed to symptom-free people are not recommended by major evidence bodies. They frequently surface incidental findings of uncertain meaning and have not been shown to extend life, while reliably generating worry and follow-up tests.

My father, in his late 60s, was convinced that more scans meant more safety, and he wanted the full private package “just to be sure.” What actually changed his health was duller and cheaper: a blood pressure reading at a routine visit that turned out to be high, and a DXA scan after a minor wrist fracture that revealed thinning bone in time to do something about it. Neither was dramatic. Both were the right test at the right time, and that, far more than volume, is what good screening in later life looks like.

This article is general information, not medical advice. Speak to a qualified clinician about which checks are right for you at your age and stage of health.